David Brindley

Founder and Academic Director
CASMI

Regenerative Medicine: Hype, Hope and Emerging Clinical Realities

David is an international thought-leader in healthcare risk management, with a particular interest in regenerative medicines. His multi-disciplinary research seeks to evaluate and develop systematic, rigorous and transparent risk management tools supporting the translation of life-science innovations into commercially viable products and services.

Buttontwitter Buttonlinkedin

As Featured In

Original
Original
Original
Original
Original
Original

Partners & Attendees

Intel.001
Nvidia.001
Graphcoreai.001
Ibm watson health 3.001
Facebook.001
Acc1.001
Rbc research.001
Twentybn.001
Forbes.001
Maluuba 2017.001
Mit tech review.001
Kd nuggets.001